Accelerated removal of antibody-coated red blood cells from the circulation is accurately tracked by a biotin label

Transfusion

Volumn 52, Issue 5, 2012, Pages 1097-1105

  Mock, Donald M ^a,b,c   Lankford, Gary L ^a,b,c   Matthews, Nell I ^a,b,c   Burmeister, Leon F ^a,b,c   Kahn, Daniel ^a,b,c   Widness, John A ^a,b,c   Strauss, Ronald G ^a,b,c  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOTIN; CHROMIUM 51; IMMUNOGLOBULIN G; RHESUS D ANTIGEN;

ADULT; ALLOIMMUNITY; ANTIBODY LABELING; APHERESIS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CELL TRACKING; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE LIFESPAN; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOLYTIC ANEMIA; HUMAN; ISOTOPE LABELING; MALE;

BIOTIN; CELL SURVIVAL; CHROMIUM RADIOISOTOPES; ERYTHROCYTES; HUMANS; ISOANTIBODIES;

EID: 84861097066     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03397.x     Document Type: Article

References (25)

1. International Committee for Standardization in Haematology. Recommended methods for radioisotope red-cell survival studies. Br J Haematol 1980; 45: 659-66.
2. Franco RS, Lohmann J, Silverstein EB, Mayfield-Pratt G, Rucknagel DL, Joiner CH, Weiner M,. The use of biotinylated RBC to determine the in vivo survival characteristics of normal and sickle cells. Blood 1996; 88: 11A.
3. Russo V, Barker-Gear R, Gates R, Franco R,. Studies with biotinylated RBC: (1) use of flow cytometry to determine posttransfusion survival and (2) isolation using streptavidin conjugated magnetic beads. In:, Magnani M, DeLoach JR, editors. The use of resealed erythrocytes as carriers and bioreactors. New York: Plenum Press; 1992. p. 101-7.
4. Franco RS, Lohmann J, Silbertein EB, Mayfiled-Pratt G, Palascak M, Nemeth TA, Joiner CH, Weiner M, Rucknagel DL,. Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells. J Clin Invest 1998; 101: 2730-40.
5. Hudson I, Cooke A, Holland B, Houston A, Jones JG, Turner T, Wardrop CA,. Red cell volume and cardiac output in anaemic preterm infants. Arch Dis Child 1990; 65: 672-5.
6. Hudson IR, Cavill IA, Cooke A, Holland BM, Hoy TG, Trevett D, Turner TL, Wardrop CA,. Biotin labeling of red cells in the measurement of red cell volume in preterm infants. Pediatr Res 1990; 28: 199-202.
7. Holland BM, Wardrop CA,. Anaemias of the preterm infant. In:, Turner TL, editor. Perinatal haematological problems. London: John Wiley & Sons, Ltd.; 1991. p. 121-35.
8. Aladangady N, McHugh S, Aitchison TC, Wardrop CA, Holland BM,. Infants' blood volume in a controlled trial of placental transfusion at preterm delivery. Pediatrics 2006; 117: 93-8.
9. Aladangady N, Aitchison TC, Beckett C, Holland BM, Kyle BM, Wardrop CA,. Is it possible to predict the blood volume of a sick preterm infant? Arch Dis Child Fetal Neonatal Ed 2004; 89: F344-7.
10. 51Cr labeled red cells. Transfusion 1999; 39: 156-62.
11. Mock DM, Matthews NI, Zhu S, Strauss RG, Schmidt RL, Nalbant D, Cress GA, Widness JA,. Red blood cell (RBC) survival determined in humans using RBCs labeled at multiple biotin densities. Transfusion 2011; 51: 1047-57.
12. International Committee for Standardization in Haematology. Recommended methods for radioisotope red-cell survival studies. Br J Nutr 1971; 21: 241-50.
13. 51Cr survival curves. Br J Haematol 1971; 20: 527-36.
14. 51Cr labeled red cells. Transfusion 1999; 39: 149-55.
15. Mock DM, Matthews NI, Strauss RG, Burmeister LF, Schmidt R, Widness JA,. Red blood cell volume can be independently determined in vitro using sheep and human red cells labeled at different densities of biotin. Transfusion 2009; 49: 1178-85.
16. International Committee for Standardization in Haematology. Recommended methods for measurement of red-cell and plasma volume. J Nucl Med 1980; 21: 793-800.
17. Fresco R, Busch S, Hanson ML, Huestis DW,. A simple method of preparing "coated" red blood cells for use as a control in antiglobulin testing. Transfusion 1964; 4: 262-4.
18. Cordle DG, Strauss RG, Lankford GL, Mock DM,. Antibodies provoked by the transfusion of biotin-labeled red cells. Transfusion 1999; 39: 1065-9.
19. 14C]cyanate label. Pediatr Res 1997; 41: 916-21.
20. Mollison PL, Engelfriet CP, Conteras M,. Blood transfusion in clinical medicine. London: Blackwell Scientific Publications; 1993.
21. Mollison P, Crome P, Hughes-Jones N, Rochna E,. Rate of removal from the circulation of red cells sensitized with different amounts of antibody. Transfusion 1965; 11: 461-70.
22. Hoffmann-Fezer G, Mysliwietz J, Mortlbauer W, Zeitler JJ, Eberle E, Honle U, Thierfelder S,. Biotin labeling as an alternative nonradioactive approach to determination of red cell survival. Ann Hematol 1993; 67: 81-7.
23. Strauss RG, Burmeister LF, Johnson K, James T, Miller J, Cordle DG, Bell EF, Ludwig GA,. AS-1 red blood cells for neonatal transfusions: a randomized trial assessing donor exposure and safety. Transfusion 1996; 36: 873-8.
24. Bifano EM, Dracker RA, Lorah K, Palit A,. Collection and 28-day storage of human placental blood. Pediatr Res 1994; 36: 90-4.
25. Widness JA, Strauss RG,. Recombinant erythropoietin in treatment of the premature newborn. Semin Neonatol 1998; 3: 163-71.